NervGen Pharma Prices $60 Million Public Offering
NervGen Pharma Corp. has priced a public offering of common shares and warrants, raising $60 million to advance its neuroreparative therapeutics.

NervGen Pharma Corp. has priced a public offering of common shares and warrants, raising $60 million to advance its neuroreparative therapeutics.

Deckers Outdoor Corporation projects FY 2027 revenue between $5.86B-$5.91B and EPS of $7.30-$7.45, with sustained high single-digit growth anticipated through FY 2030.

Nvidia reported record Q1 revenue of $81.6bn and net income of $58.3bn, yet its shares fell 1.6% after-hours as investors question growth...

Gold prices dipped toward $4,500 an ounce on Thursday, influenced by a strong dollar, rising Treasury yields, and ongoing U.S.-Iran peace negotiations....

Lean hog futures experienced a significant downturn on Thursday, with contracts losing up to $2.15. USDA data indicated a slight dip in...

Brussels reevaluates its landmark MiCA crypto framework just two years post-implementation, while Washington pushes for blockchain adoption and innovation.

Anker Innovations showcased next-generation products across its brands at Anker Day 2026, featuring proprietary AI chip platform THUS™ and new home energy...

Workday (WDAY) forecasts FY '27 subscription revenue between $9.925B and $9.950B, while raising its non-GAAP operating margin target to 30.5%. The outlook...

Chancellor Rachel Reeves announced a surprise VAT cut on summer attractions, aiming to ease cost-of-living pressures. The move was not pre-briefed.

Japan's exports surged 14.8% in April, defying concerns over oil and gas supplies due to the Iran conflict. Trade balance shifted to...

Gold prices saw a modest increase on Thursday, with gains capped by ongoing U.S.-Iran geopolitical tensions, including conflicting reports on enriched uranium...

China's stock market has fallen for two consecutive sessions, with the Shanghai Composite Index down over 2.2%. Analysts anticipate a potential halt...